Braveheart

Developer of a treatment for hypertrophic cardiomyopathy and related conditions

placeSan Francisco, California, United States calendar_todayFounded 2025 language braveheart.bio

Social engagement

Social engagement: 3.3K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital480%
Other / undisclosed120%

Recent activity

26 Mar 2026
Leadership hire
Chief Medical Officer
5 Feb 2026
Leadership hire
Chief Scientific Officer
6 Jan 2026
Event
44th Annual J.P. Morgan Healthcare Conference
Coming soon